MAM evidence brief – key results
This technical brief presents the key results from the MAMaZ Against Malaria (MAM) project which was established in July 2017.
MAMaZ against Malaria is a one year pilot project, funded by the Geneva-based foundation, Medicines for Malaria Venture (MMV). The project aims to devise an evidence-based and sustainable strategy to improve the access of hard-to-reach communities to effective treatment for severe malaria (SM) in a high malaria burden setting.
The project is being implemented by a consortium led by Transaid in partnership with Health Partners Zambia, Development Data and Disacare. The consortium is working in partnership with the Ministry of Health in Zambia, specifically the National Malaria Elimination Centre, and the District Health Management Team for Serenje District.
To read this report, please click below.